Capricor Therapeutics, Inc. ( CAPR) - Stock Earnings
CAPR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -24.6 million USD | — USD |
| 2025Q4 | -30.2 million USD | — USD |
| 2026Q1 | -33.9 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CAPR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.3 million USD | 25.2 million USD |
| 2024 | -40.5 million USD | 22.3 million USD |
| 2025 | -105.0 million USD | — USD |
| 2026 Est. | — | — |
CAPR
Price: $26.72
52 week price:
Earnings Per Share: -2.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 60100
Ebitda: -2.6 millionMarket Capitalization: 1.2 billion